Answers are grounded in this paper and cite their sources.
Purpose Assess coded ophthalmic manifestations in individuals diagnosed with Williams Syndrome (WS) compared to age- and sex-matched controls. Methods Study population: Subjects diagnosed with Williams Syndrome. Procedures: Retrospective observational study using the TriNetX United States Network. Williams syndrome was identified with ICD-10-CM code Q93.82, which became effective on October 1, 2018. Subjects with WS and ophthalmologic conditions (hypertropia, esotropia, exotropia, hypermetropia, myopia, astigmatism, degenerative myopia, amblyopia, keratoconus, rod-cone dystrophy, congenital anterior segment dysgenesis, cataract, Peters anomaly, megalocornea, and optic nerve hypoplasia) were identified using ICD-10-CM codes. Demographic data recorded included age, sex, race, and ethnicity. Outcomes Outcomes included the frequency of coded ophthalmic diagnoses within the WS cohort and comparative risk estimates between WS and matched controls. Results A total of 1,232 subjects met the WS cohort criteria, and 1,198 WS subjects were matched 1:1 to 1,198 controls. Astigmatism (11.0%) and hypermetropia (10.0%) were the most frequent estimable post-index diagnoses. WS was associated with higher risk of astigmatism (RR = 3.53, 95% CI 2.47-5.04), hypermetropia (RR = 5.70, 95% CI 3.61-9.01), myopia (RR = 1.85, 95% CI 1.21-2.83), and cataract (RR = 2.43, 95% CI 1.28-4.61); all remained significant after false-discovery-rate correction. Conclusions In the US, coded refractive errors were the most consistently elevated ophthalmic findings in WS, while several rarer outcomes could not be precisely estimated. These findings underscore the importance of early vision screening and point to the utility of EHR-based platforms in characterizing rare diseases across populations.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: